Agency Information Collection Activities: Proposed Collection; Comment Request, 101606-101607 [2024-29458]

Download as PDF 101606 Federal Register / Vol. 89, No. 241 / Monday, December 16, 2024 / Notices lotter on DSK11XQN23PROD with NOTICES1 including at the clinician-patient level, practice level, and health-system level. Additionally, the Task Force benefits from members with expertise in the following areas: D Public Health D Health Equity and The Reduction of Health Disparities D Application of Science to Health Policy D Decision modeling D Dissemination and Implementation D Behavioral Medicine/Clinical Health Psychology D Communication of Scientific Findings to Multiple Audiences Including Health Care Professionals, Policy Makers, and the General Public. Candidates with experience and skills in any of these areas should highlight them in their nomination materials. Applicants must have no substantial conflicts of interest, whether financial, professional, or intellectual, that would impair the scientific integrity of the work of the USPSTF and must be willing to complete regular conflict of interest disclosures. Applicants must have the ability to work collaboratively with a team of diverse professionals who support the mission of the USPSTF. Applicants must have adequate time to contribute substantively to the work products of the USPSTF. Nominee Selection Nominated individuals will be selected for the USPSTF on the basis of how well they meet the required qualifications, and the current expertise needs of the USPSTF. It is anticipated that new members will be invited to serve on the USPSTF beginning in January, 2026. All nominated individuals will be considered; however, strongest consideration will be given to individuals with demonstrated training and expertise in the areas of Family Medicine, Pediatrics, Behavioral Medicine, and Obstetrics and Gynecology. AHRQ will retain and may consider for future vacancies nominations received this year and not selected during this cycle. Some USPSTF members without primary health care clinical experience may be selected based on their expertise in methodological issues such as metaanalysis, analytic modeling, or clinical epidemiology. For individuals with clinical expertise in primary health care, additional qualifications in methodology would enhance their candidacy. Background Under title IX of the Public Health Service Act, AHRQ is charged with VerDate Sep<11>2014 17:41 Dec 13, 2024 Jkt 265001 enhancing the quality, appropriateness, and effectiveness of health care services and access to such services. 42 U.S.C. 299(b). AHRQ accomplishes these goals through scientific research and promotion of improvements in clinical practice, including clinical prevention of diseases and other health conditions. See 42 U.S.C. 299(b). The USPSTF, a body of experts in prevention and evidence-based medicine, works to improve the health of people nationwide by making evidence-based recommendations about the effectiveness of clinical preventive services and health promotion. The recommendations made by the USPSTF address clinical preventive services for adults and children, and include screening tests, counseling services, and preventive medications. The USPSTF was first established in 1984 under the auspices of the U.S. Public Health Service. AHRQ provides ongoing scientific, administrative, and dissemination support for the USPSTF’s operation. See 42 U.S.C. 299b-4(a)(3). Members are appointed by the Secretary of the U.S. Department of Health and Human Services to serve four-year terms. New members are selected each year to replace those members who are completing their appointments. The USPSTF rigorously evaluates the effectiveness of clinical preventive services and formulating or updating recommendations regarding the appropriate provision of preventive services. Current USPSTF recommendations and associated evidence reviews are available on the internet (www.uspreventiveservices taskforce.org). USPSTF members meet three times a year for two days in the Washington, DC area or virtually if necessary. A significant portion of the USPSTF’s work occurs between meetings during video conference calls and via email discussions. Member duties include prioritizing topics, designing research plans, reviewing and commenting on systematic evidence review reports, discussing evidence and making recommendations on preventive services, reviewing stakeholder comments, drafting final recommendation documents, and participating in workgroups on specific topics and methods. Members can expect to receive frequent emails, can expect to participate in multiple video conference calls each month, and can expect to have periodic interaction with stakeholders. AHRQ estimates that members devote approximately 250 hours a year outside of in-person meetings to their USPSTF duties. The members are all volunteers and do not PO 00000 Frm 00058 Fmt 4703 Sfmt 4703 receive any compensation beyond support for travel to attend the thrice yearly meetings and trainings. Dated: December 10, 2024. Marquita Cullom, Associate Director. [FR Doc. 2024–29479 Filed 12–13–24; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifiers: CMS–10538] Agency Information Collection Activities: Proposed Collection; Comment Request Centers for Medicare & Medicaid Services, Health and Human Services (HHS). ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information (including each proposed extension or reinstatement of an existing collection of information) and to allow 60 days for public comment on the proposed action. Interested persons are invited to send comments regarding our burden estimates or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments must be received by February 14, 2025. ADDRESSES: When commenting, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in any one of the following ways: 1. Electronically. You may send your comments electronically to https:// www.regulations.gov. Follow the instructions for ‘‘Comment or Submission’’ or ‘‘More Search Options’’ to find the information collection SUMMARY: E:\FR\FM\16DEN1.SGM 16DEN1 Federal Register / Vol. 89, No. 241 / Monday, December 16, 2024 / Notices document(s) that are accepting comments. 2. By regular mail. You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development. Attention: Document Identifier/OMB Control Number: ll, Room C4–26–05, 7500 Security Boulevard, Baltimore, Maryland 21244–1850. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, please access the CMS PRA website by copying and pasting the following web address into your web browser: https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing. FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: lotter on DSK11XQN23PROD with NOTICES1 Contents This notice sets out a summary of the use and burden associated with the following information collections. More detailed information can be found in each collection’s supporting statement and associated materials (see ADDRESSES). CMS–10538 Hospice Information for Medicare Part D Plans Under the PRA (44 U.S.C. 3501– 3520), Federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and includes agency requests or requirements that members of the public submit reports, keep records, or provide information to a third party. Section 3506(c)(2)(A) of the PRA requires Federal agencies to publish a 60-day notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, before submitting the collection to OMB for approval. To comply with this requirement, CMS is publishing this notice. Information Collections 1. Type of Information Collection Request: Reinstatement without change of a previously approved collection; Title of Information Collection: Hospice Information for Medicare Part D Plans; Use: The Social Security Act in section 1861(dd) and Federal regulations in 42 CFR 418.106 and 418.202(f) require hospice programs to provide individuals VerDate Sep<11>2014 17:41 Dec 13, 2024 Jkt 265001 under hospice care with drugs and biologicals related to the palliation and management of the terminal illness as defined in the hospice plan of care. Medicare payment is made to the hospice for each day an eligible beneficiary is under the hospice’s care, regardless of the amount of services provided on any given day. Because hospice care is a Medicare Part A benefit, drugs provided by the hospice and covered under the Medicare payment to the hospice program are not covered under Part D. The form would be completed by the prescriber or the beneficiary’s hospice, or if the prescriber or hospice provides the information verbally to the Part D sponsor, the form would be completed by the sponsor. Information provided on the form would be used by the Part D sponsor to establish coverage of the drug under Medicare Part D. Per statute, drugs that are necessary for the palliation and management of the terminal illness and related conditions are not eligible for payment under Part D. The standard form provides a vehicle for the hospice provider, prescriber or sponsor to document that the drug prescribed is ‘‘unrelated’’ to the terminal illness and related conditions. It also gives a hospice organization the option to communicate a beneficiary’s change in hospice status and/care plan to Part D sponsors. Form Number: CMS– 10538 (OMB control number: 0938– 1296); Frequency: Yearly; Affected Public: Private Sector (business or other for-profits); Number of Respondents: 319; Number of Responses: 57,027; Total Annual Hours: 2,329. (For policy questions regarding this collection, contact Chad Buskirk at (410) 786–1630 or chad.buskirk@cms.hhs.gov.) William N. Parham, III, Director, Division of Information Collections and Regulatory Impacts, Office of Strategic Operations and Regulatory Affairs. [FR Doc. 2024–29458 Filed 12–13–24; 8:45 am] BILLING CODE 4120–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES RIN 0917–AA25 Reimbursement Rates for Calendar Year 2025 Indian Health Service, HHS. ACTION: Notice. AGENCY: Notice is provided that the Director of the Indian Health Service (IHS) has approved the rates for inpatient and outpatient medical care PO 00000 Frm 00059 Fmt 4703 Sfmt 4703 provided by the IHS facilities for Calendar Year 2025. SUPPLEMENTARY INFORMATION: Background The Director of the Indian Health Service, under the authority of sections 321(a) and 322(b) of the Public Health Service Act (42 U.S.C. 248 and 249(b)), Public Law 83–568 (42 U.S.C. 2001(a)), and the Indian Health Care Improvement Act (25 U.S.C. 1601 et seq.), has approved the following rates for inpatient and outpatient medical care provided by IHS facilities for Calendar Year 2025 for Medicare and Medicaid beneficiaries, beneficiaries of other Federal programs, and for recoveries under the Federal Medical Care Recovery Act (42 U.S.C. 2651– 2653). The inpatient rates for Medicare Part A are excluded from the table below. That is because Medicare inpatient payments for IHS hospital facilities are made based on the prospective payment system, or (when IHS facilities are designated as Medicare Critical Access Hospitals) on a reasonable cost basis. Since the inpatient per diem rates set forth below do not include all physician services and practitioner services, additional payment shall be available to the extent that those services are provided. Please note that the Centers for Medicare and Medicaid Services (CMS) has issued a Final Rule to pay an addon to the Medicare Outpatient Per Visit Rate listed below for certain high-cost drugs for people with Medicare who receive care at IHS or Tribal hospitals. See 89 FR 93912, (November 27, 2024), also available at https:// www.federalregister.gov/documents/ 2024/11/27/2024-25521/medicare-andmedicaid-programs-hospital-outpatientprospective-payment-and-ambulatorysurgical. Further information regarding this proposal will be issued directly from CMS. Inpatient Hospital Per Diem Rate (Excludes Physician/Practitioner Services) Calendar Year 2025 Lower 48 States: $5,580. Alaska: $5,074. Indian Health Service SUMMARY: 101607 Outpatient Per Visit Rate (Excluding Medicare) Calendar Year 2025 Lower 48 States: $801. Alaska: $1,209. Outpatient Per Visit Rate (Medicare) Calendar Year 2025 Lower 48 States: $718. E:\FR\FM\16DEN1.SGM 16DEN1

Agencies

[Federal Register Volume 89, Number 241 (Monday, December 16, 2024)]
[Notices]
[Pages 101606-101607]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-29458]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Medicare & Medicaid Services

[Document Identifiers: CMS-10538]


Agency Information Collection Activities: Proposed Collection; 
Comment Request

AGENCY: Centers for Medicare & Medicaid Services, Health and Human 
Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Medicare & Medicaid Services (CMS) is 
announcing an opportunity for the public to comment on CMS' intention 
to collect information from the public. Under the Paperwork Reduction 
Act of 1995 (PRA), Federal agencies are required to publish notice in 
the Federal Register concerning each proposed collection of information 
(including each proposed extension or reinstatement of an existing 
collection of information) and to allow 60 days for public comment on 
the proposed action. Interested persons are invited to send comments 
regarding our burden estimates or any other aspect of this collection 
of information, including the necessity and utility of the proposed 
information collection for the proper performance of the agency's 
functions, the accuracy of the estimated burden, ways to enhance the 
quality, utility, and clarity of the information to be collected, and 
the use of automated collection techniques or other forms of 
information technology to minimize the information collection burden.

DATES: Comments must be received by February 14, 2025.

ADDRESSES: When commenting, please reference the document identifier or 
OMB control number. To be assured consideration, comments and 
recommendations must be submitted in any one of the following ways:
    1. Electronically. You may send your comments electronically to 
https://www.regulations.gov. Follow the instructions for ``Comment or 
Submission'' or ``More Search Options'' to find the information 
collection

[[Page 101607]]

document(s) that are accepting comments.
    2. By regular mail. You may mail written comments to the following 
address: CMS, Office of Strategic Operations and Regulatory Affairs, 
Division of Regulations Development. Attention: Document Identifier/OMB 
Control Number: __, Room C4-26-05, 7500 Security Boulevard, Baltimore, 
Maryland 21244-1850.
    To obtain copies of a supporting statement and any related forms 
for the proposed collection(s) summarized in this notice, please access 
the CMS PRA website by copying and pasting the following web address 
into your web browser: https://www.cms.gov/Regulations-and-Guidance/Legislation/PaperworkReductionActof1995/PRA-Listing.

FOR FURTHER INFORMATION CONTACT: William N. Parham at (410) 786-4669.

SUPPLEMENTARY INFORMATION:

Contents

    This notice sets out a summary of the use and burden associated 
with the following information collections. More detailed information 
can be found in each collection's supporting statement and associated 
materials (see ADDRESSES).

CMS-10538 Hospice Information for Medicare Part D Plans

    Under the PRA (44 U.S.C. 3501-3520), Federal agencies must obtain 
approval from the Office of Management and Budget (OMB) for each 
collection of information they conduct or sponsor. The term 
``collection of information'' is defined in 44 U.S.C. 3502(3) and 5 CFR 
1320.3(c) and includes agency requests or requirements that members of 
the public submit reports, keep records, or provide information to a 
third party. Section 3506(c)(2)(A) of the PRA requires Federal agencies 
to publish a 60-day notice in the Federal Register concerning each 
proposed collection of information, including each proposed extension 
or reinstatement of an existing collection of information, before 
submitting the collection to OMB for approval. To comply with this 
requirement, CMS is publishing this notice.

Information Collections

    1. Type of Information Collection Request: Reinstatement without 
change of a previously approved collection; Title of Information 
Collection: Hospice Information for Medicare Part D Plans; Use: The 
Social Security Act in section 1861(dd) and Federal regulations in 42 
CFR 418.106 and 418.202(f) require hospice programs to provide 
individuals under hospice care with drugs and biologicals related to 
the palliation and management of the terminal illness as defined in the 
hospice plan of care. Medicare payment is made to the hospice for each 
day an eligible beneficiary is under the hospice's care, regardless of 
the amount of services provided on any given day. Because hospice care 
is a Medicare Part A benefit, drugs provided by the hospice and covered 
under the Medicare payment to the hospice program are not covered under 
Part D.
    The form would be completed by the prescriber or the beneficiary's 
hospice, or if the prescriber or hospice provides the information 
verbally to the Part D sponsor, the form would be completed by the 
sponsor. Information provided on the form would be used by the Part D 
sponsor to establish coverage of the drug under Medicare Part D. Per 
statute, drugs that are necessary for the palliation and management of 
the terminal illness and related conditions are not eligible for 
payment under Part D. The standard form provides a vehicle for the 
hospice provider, prescriber or sponsor to document that the drug 
prescribed is ``unrelated'' to the terminal illness and related 
conditions. It also gives a hospice organization the option to 
communicate a beneficiary's change in hospice status and/care plan to 
Part D sponsors. Form Number: CMS-10538 (OMB control number: 0938-
1296); Frequency: Yearly; Affected Public: Private Sector (business or 
other for-profits); Number of Respondents: 319; Number of Responses: 
57,027; Total Annual Hours: 2,329. (For policy questions regarding this 
collection, contact Chad Buskirk at (410) 786-1630 or 
[email protected].)

William N. Parham, III,
Director, Division of Information Collections and Regulatory Impacts, 
Office of Strategic Operations and Regulatory Affairs.
[FR Doc. 2024-29458 Filed 12-13-24; 8:45 am]
BILLING CODE 4120-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.